Delhi-based healthcare firm Vyome Therapeutics on Thursday said it has raised $22 million in a Series D round of funding led by Mumbai-based venture growth fund Iron Pillar. The funding round saw participation from existing investors Kalaari Capital, Perceptive Advisors and Romulus Capital. The company revealed it will use the funds to advance its lead molecule to fight antibiotic-resistant acne.